Skip to main content
Premium Trial:

Request an Annual Quote

Syapse Raises $68M in Equity Financing

NEW YORK – Syapse said Tuesday that it has raised $68 million in new equity financing. Ally Bridge Group led the round, with participation from new investor Northpond Ventures and several unspecified existing investors.

As a result of the investment, Northpond Ventures Director Andrea Jackson has been named to the Syapse board of directors. 

In a statement, Jackson said that Syapse's strategy of applying real-world data and evidence to cancer care is "foundational for drug developers, regulators, doctors, and caregivers."

Syapse, a San Francisco-based maker of software to support precision oncology care and drug discovery, said that it would use the money to expand its network of partnerships with life sciences companies, health systems, molecular laboratories, and regulators.

The firm did not name this investment round, but this is Syapse's second major funding announcement since a $30 million Series D round in November 2017, following an unnamed $30 million round in May 2020.

The Stanford University spinoff has now landed at least $166 million in venture investments since its inception in 2014. 

"We are extremely pleased that Ally Bridge Group and Northpond Ventures embrace our vision of providing high-quality healthcare to cancer patients, and building a global network that integrates a great deal of provider-driven data to deliver actionable insights to health systems and their patients," Syapse CEO Ken Tarkoff said in a statement.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.